LGND — Ligand Pharmaceuticals Incorporated

$271.46

Dividend YieldN/A

Annual DividendN/A

Payout Ratio

Safe34.10%

Consecutive Years0 yrs

Frequencyirregular

Next Ex-Date

N/A

View full dividend history →

1-Year Growth

N/A

3-Year Growth

N/A

5-Year Growth

N/A

10-Year Growth

N/A

Key Dividend Dates

Next Ex-Date

N/A

Next Payment

N/A

Last Ex-Date

Jul 2, 2010

Last Payment

Jul 1, 2010

Dividend History

Ex-Date	Payment Date	Amount	Type	Change
Jul 2, 2010	Jul 1, 2010	$0.0763	Cash	-96.95%
Apr 3, 2007	Apr 19, 2007	$2.5000	Cash	N/A

Payout Ratio (Earnings)

34.1%

Safe

FCF Payout Ratio

N/A

Financial Snapshot

Period	Revenue	Net Income	EPS	FCF
Q1 2026	$51.72M	-$13.35M	$-0.67	$48.46M
Q1 2025	$45.33M	-$42.45M	$-2.21	-$25.73M
Q2 2025	$47.63M	$4.85M	$0.25	$15.58M
Q3 2025	$115.46M	$117.27M	$5.99	$13.07M

Analyst Ratings (Last 90 Days)

Buy: 0Hold: 6Sell: 0

Peer Comparison

Symbol	Company	Yield	Payout	Years	Growth 5Y	Market Cap
REGN	Regeneron Pharmaceuticals, Inc.	0.60%	8.90%	0	N/A	$63.06B
RPRX	Royalty Pharma plc	1.73%	51.40%	5	24.01%	$23.32B
TECH	Bio-Techne Corporation	0.55%	62.70%	0	0.00%	$8.61B
XOMAO	XOMA Corporation	8.23%	133.40%	0	N/A	$524M
SVA	Sinovac Biotech Ltd.	3400.31%	N/A	0	N/A	$465M

Compare LGND:

LGND vs REGN LGND vs RPRX LGND vs TECH LGND vs XOMAO

About this data

Dividend data sourced from Financial Modeling Prep. Prices updated daily after market close.

Payout ratio — trailing 12-month dividends paid / trailing 12-month net income.

Consecutive years — calendar years with a higher total annual dividend than the prior year.

Growth rates — annualized, comparing the most recent full year total to the total N years prior.

For informational purposes only. Not investment advice.

Data as of June 20, 2026. Source: Financial Modeling Prep. Prices and yields updated daily after market close.